跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTAVANZ lisdexamfetamine dimesilate 30 mg capsules bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ACTAVANZ lisdexamfetamine dimesilate 30 mg capsules bottle
Approved
STANDARD
ACTAVANZ lisdexamfetamine dimesilate 30 mg capsules bottle
Actor Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6fdf608e3b6a014b
Company
Actor Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
6fdf608e3b6a014b
Product Name
ACTAVANZ lisdexamfetamine dimesilate 30 mg capsules bottle
Artg Id
406917
Artg Name
ACTAVANZ lisdexamfetamine dimesilate 30 mg capsules bottle
Sponsor
Actor Pharmaceuticals Pty Ltd
Company Detail Path
/organization/actor-pharmaceuticals-pty-ltd
Artg Date
2024-01-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6fdf608e3b6a014b
Type
Standard
Back to TGA Approvals
